Patents by Inventor Manfred Boese

Manfred Boese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6977083
    Abstract: The method of making a bioadhesive tablet for controlling testosterone blood level, especially in elderly men suffering from partial androgen deficiency, includes spray-drying an alcoholic solution or suspension of testosterone and at least one testosterone ester, preferably in a ratio of 1:10 to 1:1.5, separately or together, with an organic polymer and optionally one or more auxiliary ingredient to form an active ingredient premix. Then various other auxiliary ingredients are mixed, as needed, with the active ingredient premix to form the bioadhesive tablet with an active ingredient layer and an adhesive layer. The active ingredient layer contains an effective amount of the active ingredient premix. The adhesive layer includes auxiliary ingredients including the bioadhesive polymer. The bioadhesive tablet may be buccally administered to provide a predetermined timed release profile of testosterone, advantageously varying according to a circadian rhythm.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: December 20, 2005
    Assignee: Jenapharm GmbH & Co. KG
    Inventors: Doris Huebler, Guenter Kaufmann, Michael Oettel, Holger Zimmermann, Michael Dittgen, Sabine Fricke, Manfred Boese, Ralf Ladwig, Sven Claussen, Carsten Timpe
  • Patent number: 4731394
    Abstract: The invention relates to inorganic-organic compound substances useful for biomedical purposes. The object of the invention is to develop inorganic-organic compound materials which overcome the disadvantages of the state of art, wherein inorganic-organic compound substances for biomedical purposes possess to a large extent specifically adjustable characteristics. Inorganic initial substances form a new solid chemical compound with organic initial substances. The inorganic initial component consists of a biocompatible silicate glass and/or a silicate glass ceramic of the system SiO.sub.2 -Al.sub.2 O.sub.3 -MgO-Na.sub.2 O/K.sub.2 O-F.sup.-, and/or a bioactive phosphate silicate glass and/or a phosphate silicate glass ceramic of the system SiO.sub.2 -Al.sub.2 O.sub.3 -MgO-Na.sub.2 O/K.sub.2 O-CaO-P.sub.2 O.sub.5 F.sup.- and/or of the system SiO.sub.2 -MgO-K.sub.2 O-F.sup.- -CaO-P.sub.2 O.sub.5, and/or a bioactive phosphate glass and/or a phosphate glass ceramic of the system P.sub.2 O.sub.5 -Al.sub.2 O.sub.
    Type: Grant
    Filed: June 12, 1986
    Date of Patent: March 15, 1988
    Assignee: Friedrich-Schiller-Universitaet Jena
    Inventors: Werner Vogel, Guenther Heublein, Wolfram Hoeland, Manfred Boese, Karin Naumann, Gunter Carl, Juergen Vogel, Peter Wange, Jens Gummel, Peter Zinner, Eggert Beleites, Thomas Schubert